|
KMID : 0894520230270010001
|
|
Development & Reproduction
2023 Volume.27 No. 1 p.1 ~ p.7
|
|
|
The New Way to Define Key Oncogenic Drivers of Small Cell Lung Cancer
|
|
Kim Kee-Beom
|
|
|
Abstract
|
|
|
|
Small-cell lung cancer (SCLC) continues to be the deadliest of all lung cancer types. Its high mortality is largely attributed to the unchangeable development of resistance to standard chemo/radiotherapies, which have remained invariable for the past 30 years, underlining the need for new therapeutic approaches. Recent studies of SCLC genome revealed a large number of somatic alterations and identified remarkable heterogeneity of the frequent mutations except for the loss of both RB and P53 tumor suppressor genes (TSGs). Identifying the somatic alterations scattered throughout the SCLC genome will help to define the underlying mechanism of the disease and pave the way for the discovery of therapeutic vulnerabilities associated with genomic alterations. The new technique made it possible to determine the underlying mechanism for the discovery of therapeutic targets. To these ends, the techniques have been focused on understanding the molecular determinants of SCLC.
|
|
|
KEYWORD
|
|
|
Small-cell lung cancer (SCLC), pre-cancerous cells (preSC), Somatic engineering mouse model, Clustered regularly interspaced short palindromic repeats (CRISPR)
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|